Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

NASDAQ:TNXP

Overview | Financials
Company Name Tonix Pharmaceuticals Holding Corp.
Symbol TNXP
Currency USD
Price 0.37
Market Cap 69,150,780
Dividend Yield 0%
52-week-range 0.12 - 14.08
Industry Biotechnology
Sector Healthcare
CEO Dr. Seth Lederman M.D.
Website https://www.tonixpharma.com

An error occurred while fetching data.

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address

Related Stocks

Immunome, Inc. logo

Immunome, Inc.

IMNM

11.1 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

0.806 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

2.49 USD

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

1.19 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

11.97 USD

Nutriband Inc. logo

Nutriband Inc.

NTRB

3.95 USD

Financials

Numbers are in millions USD

Numbers are in millions USD